Clinical trial
SPECTACL: SPECTroscopic Assessment of Coronary Lipid
NCT00330928 · Infraredx, Industry · Completed
Key facts
| NCT number | NCT00330928 |
|---|---|
| Title | SPECTACL: SPECTroscopic Assessment of Coronary Lipid |
| Official title | Coronary Artery Plaque Characterization by NIR Spectroscopy in Patients Undergoing Elective Percutaneous Coronary Intervention |
| Acronym | SPECTACL |
| Lead sponsor | Infraredx, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Angina Pectoris, Angina, Unstable, Myocardial Infarction |
| Intervention type | Device |
| Interventions | Near Infrared Spectroscopy (NIRS) Imaging, intravascular ultrasound (IVUS) |
| Enrollment | 106 |
| Start date | Jan 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2008 |
| First posted | May 29, 2006 |
| Last update posted | Jan 5, 2021 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: